NUTRAY PHARMA SL
Company details
- Active NIF/CIF: B91485987
-
Telephone: Not available
-
Date of last BORME entry: 10/03/2010
-
Sector: Manufacturing
-
Address: C/ CARLOS CANO 3 - ALTOS CASTILLEJA (CASTILLEJA DE LA CUESTA) See in map
-
Website: Not available
-
Featured products:
More information on NUTRAY PHARMA SL
-
10/03/2010 | BORME act no.: 124883 | Register: SEVILLADepósito de cuentas anuales (Febrero de 2010) -
10/03/2010 | BORME act no.: 125058 | Register: SEVILLADepósito de cuentas anuales (Febrero de 2010)
-
21/09/2006 | BORME act no.: 521175 | Register: SEVILLADepósito de cuentas anuales (Septiembre de 2006)
-
23/05/2006 | BORME act no.: 264090 | Register: SEVILLAConstitución
-
23/05/2006 | BORME act no.: 264090 | Register: SEVILLADeclaración de unipersonalidad
-
23/05/2006 | BORME act no.: 264090 | Register: SEVILLANombramientos
Other information
The CIF assigned to NUTRAY PHARMA SL is B91485987, and its commercial status is active. The company carries out its operations within the CNAE 1086 - Elaboración de preparados alimenticios homogeneizados y alimentos dietéticos. Likewise, its SIC code - identifies it.
NUTRAY PHARMA SL employs a team of Between 10 and 49 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Sevilla and has 2 registration charges. The last announcement in Borme was published on 10/03/2010, while the most recent deposit of ordinary annual accounts is from the year -.
To access the contact information of NUTRAY PHARMA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about NUTRAY PHARMA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about NUTRAY PHARMA SL comes from official sources and is regularly updated.
Do you want to know more about NUTRAY PHARMA SL??
Find out more about this company by consulting these reports:
